Progress in Cell Cycle Research

0.9(top 50%)

impact factor

54(top 100%)

papers

1.3K(top 50%)

citations

21(top 50%)

h-index

0.9(top 50%)

extended IF

all documents

1.3K

doc citations

34(top 50%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Cyclin B1 and CDK1: nuclear localization and upstream regulators	Progress in Cell Cycle Research	2003	116
2	Tubulin and microtubules as targets for anticancer drugs	Progress in Cell Cycle Research	2003	84
3	Survivin in apoptosis control and cell cycle regulation in cancer	Progress in Cell Cycle Research	2003	82
4	Cell cycle deregulation: a common motif in cancer	Progress in Cell Cycle Research	2003	62
5	Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs	Progress in Cell Cycle Research	2003	58
6	The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation	Progress in Cell Cycle Research	2003	52
7	The role of ATM and ATR in DNA damage-induced cell cycle control	Progress in Cell Cycle Research	2003	51
8	The actin cytoskeleton as a therapeutic target: state of the art and future directions	Progress in Cell Cycle Research	2003	39
9	The mitotic checkpoint: a signaling pathway that allows a single unattached kinetochore to inhibit mitotic exit	Progress in Cell Cycle Research	2003	37
10	The cell cycle, cyclin-dependent kinases, and viral infections: new horizons and unexpected connections	Progress in Cell Cycle Research	2003	36
11	The cell cycle and cardiovascular diseases	Progress in Cell Cycle Research	2003	31
12	Cyclin-dependent kinase inhibitors	Progress in Cell Cycle Research	2003	31
13	From DNA damage to G2 arrest: the many roles of topoisomerase II	Progress in Cell Cycle Research	2003	30
14	Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins	Progress in Cell Cycle Research	2003	29
15	The peptidyl-prolyl isomerase Pin1	Progress in Cell Cycle Research	2003	29
16	Aryl hydrocarbon receptor-mediated cell cycle control	Progress in Cell Cycle Research	2003	28
17	The cell cycle and human neurodegenerative disease	Progress in Cell Cycle Research	2003	26
18	Airway smooth muscle cell hyperplasia: a therapeutic target in airway remodeling in asthma?	Progress in Cell Cycle Research	2003	26
19	Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy	Progress in Cell Cycle Research	2003	26
20	The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle	Progress in Cell Cycle Research	2003	25
21	Phosphorylation of histone and histone-like proteins by aurora kinases during mitosis	Progress in Cell Cycle Research	2003	23
22	Yeast genomics and proteomics in drug discovery and target validation	Progress in Cell Cycle Research	2003	21
23	Regulators of nucleolar functions	Progress in Cell Cycle Research	2003	21
24	Drug discovery targeting Chk1 and Chk2 kinases	Progress in Cell Cycle Research	2003	20
25	Regulation of the eukaryotic cell cycle	Progress in Cell Cycle Research	2003	19
26	p27kip1 contributions to cancer	Progress in Cell Cycle Research	2003	19
27	Cap-dependent translation and control of the cell cycle	Progress in Cell Cycle Research	2003	19
28	Rho family-associated kinases PAK1 and rock	Progress in Cell Cycle Research	2003	17
29	Protein deacetylases: enzymes with functional diversity as novel therapeutic targets	Progress in Cell Cycle Research	2003	17
30	Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents	Progress in Cell Cycle Research	2003	17
31	The role of cyclin-dependent kinases in apoptosis	Progress in Cell Cycle Research	2003	16
32	Rheumatoid arthritis: targeting the proliferative fibroblasts	Progress in Cell Cycle Research	2003	15
33	Polo-like kinases and the microtubule organization center: targets for cancer therapies	Progress in Cell Cycle Research	2003	15
34	Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets	Progress in Cell Cycle Research	2003	14
35	HMGA proteins as therapeutic drug targets	Progress in Cell Cycle Research	2003	14
36	Roles and regulation of serine/threonine-specific protein phosphatases in the cell cycle	Progress in Cell Cycle Research	2003	14
37	The role of the replication licensing system in cell proliferation and cancer	Progress in Cell Cycle Research	2003	13
38	The contemporary drug development process: advances and challenges in preclinical and clinical development	Progress in Cell Cycle Research	2003	12
39	Inhibitors of the CDC25 phosphatases	Progress in Cell Cycle Research	2003	12
40	Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy	Progress in Cell Cycle Research	2003	11
41	Condensin and biological role of chromosome condensation	Progress in Cell Cycle Research	2003	10
42	The role of cytosolic phospholipase A2 in cell cycle progression	Progress in Cell Cycle Research	2003	8
43	Drugs affecting the cell cycle via actions on the polyamine metabolic pathway	Progress in Cell Cycle Research	2003	8
44	Dynamics of the mitotic spindle--potential therapeutic targets	Progress in Cell Cycle Research	2003	7
45	Cytometry of cell cycle regulatory proteins	Progress in Cell Cycle Research	2003	7
46	Cell cycle control in glomerular disease	Progress in Cell Cycle Research	2003	5
47	Drug discovery and the p53 family	Progress in Cell Cycle Research	2003	5
48	Small-molecule inhibitors of the cell cycle: an overview	Progress in Cell Cycle Research	2003	4
49	The development of protein farnesyltransferase inhibitors as signaling-based anticancer agents	Progress in Cell Cycle Research	2003	4
50	The cell cycle and tuberous sclerosis	Progress in Cell Cycle Research	2003	3

Scientometrics

Overviews

Citing Bodies

Progress in Cell Cycle Research

Top Articles